Patent · US Active

Anti-HCMV virus compound

US10851112B2 · kind B2 · utility

0Cited by

0References

25Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Jian Xiong · Shanghai, CN
Jingjing Wang · Shanghai, CN
Wentao Wu · Qingdao, CN
Haizhong TAN · Shanghai, CN
Xuanjia Peng · Shanghai, CN
Yang Zhang · San Diego, US
Kevin X. Chen · Edison, US
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Aug 8, 2017
Grant date	Dec 1, 2020
Priority date	—
Expiry date	Aug 8, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a class of fused cyclic compounds against the HCMV virus, and use thereof in the preparation of a drugs for treating diseases associated with the HCMV virus. In particular, disclosed is the compound shown in formula (II) and pharmaceutically acceptable salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.